GB2056982B - 2 - phenylimidazo(2,1 - b)benzothiazole derivatives - Google Patents

2 - phenylimidazo(2,1 - b)benzothiazole derivatives

Info

Publication number
GB2056982B
GB2056982B GB8027243A GB8027243A GB2056982B GB 2056982 B GB2056982 B GB 2056982B GB 8027243 A GB8027243 A GB 8027243A GB 8027243 A GB8027243 A GB 8027243A GB 2056982 B GB2056982 B GB 2056982B
Authority
GB
United Kingdom
Prior art keywords
phenylimidazo
benzothiazole derivatives
benzothiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8027243A
Other versions
GB2056982A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10643879A external-priority patent/JPS5630990A/en
Priority claimed from JP14507779A external-priority patent/JPS5668685A/en
Priority claimed from JP14844179A external-priority patent/JPS5671096A/en
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of GB2056982A publication Critical patent/GB2056982A/en
Application granted granted Critical
Publication of GB2056982B publication Critical patent/GB2056982B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB8027243A 1979-08-21 1980-08-21 2 - phenylimidazo(2,1 - b)benzothiazole derivatives Expired GB2056982B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10643879A JPS5630990A (en) 1979-08-21 1979-08-21 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation
JP14507779A JPS5668685A (en) 1979-11-09 1979-11-09 2-phenylimidazo 2,1-b benzothiazole derivative and its preparation
JP14844179A JPS5671096A (en) 1979-11-16 1979-11-16 2-phenylimidazo 2,1-b- benzothiazole derivative

Publications (2)

Publication Number Publication Date
GB2056982A GB2056982A (en) 1981-03-25
GB2056982B true GB2056982B (en) 1983-11-16

Family

ID=27310731

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8027243A Expired GB2056982B (en) 1979-08-21 1980-08-21 2 - phenylimidazo(2,1 - b)benzothiazole derivatives

Country Status (8)

Country Link
US (1) US4497817A (en)
AT (1) ATA425280A (en)
CA (1) CA1158246A (en)
DE (1) DE3030982A1 (en)
ES (1) ES8106535A1 (en)
FR (1) FR2463774A1 (en)
GB (1) GB2056982B (en)
IT (1) IT1166483B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464384A (en) * 1981-12-23 1984-08-07 Yamanouchi Pharmaceutical Co., Ltd. 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them
JP2726999B2 (en) * 1988-06-22 1998-03-11 日研化学株式会社 Imidazo [2,1-b] benzothiazole derivatives and anti-ulcer agents containing the compounds as active ingredients
IT1243362B (en) * 1990-07-25 1994-06-10 Pietro Monforte SUMMARY OF ANTI-HIV ACTIVITY OF 1H, 3H-THIAZOLE 3,4-A BENZIMIDAZOLE 1-SUBSTITUTED
EP0816366A4 (en) * 1995-03-13 1998-07-08 Nikken Chemicals Co Ltd Imidazothiazole compounds
AU3783497A (en) * 1996-08-09 1998-03-06 Yamanouchi Pharmaceutical Co., Ltd. Metabotropic glutamate receptor agonists
US6127387A (en) * 1996-12-10 2000-10-03 Thomas Jefferson University Use of CD4-binding small molecules to inhibit immune responses
AU3584200A (en) * 1999-01-29 2000-08-18 Board Of Trustees Of The University Of Illinois, The P53 inhibitors and therapeutic use of the same
DE19948436B4 (en) * 1999-10-08 2006-11-16 Grünenthal GmbH Bicyclic imidazo-5-amine derivatives
DE19948434A1 (en) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amines
US6867299B2 (en) * 2000-02-24 2005-03-15 Hoffmann-La Roche Inc. Oxamide IMPDH inhibitors
US7601846B2 (en) * 2001-06-26 2009-10-13 The Regents Of The University Of California Compounds having activity as inhibitors of apoptosis
DE10150172A1 (en) * 2001-10-11 2003-04-30 Morphochem Ag New 5-amino-4-phenyl-1H-imidazole derivatives useful as protein tyrosine phosphatase 1B inhibitors, for treating e.g. diabetes and obesity
EP1799269B1 (en) * 2004-09-28 2016-09-07 Quark Pharmaceuticals, Inc. Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
US7825099B2 (en) * 2006-01-20 2010-11-02 Quark Pharmaceuticals, Inc. Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes
US7910566B2 (en) * 2006-03-09 2011-03-22 Quark Pharmaceuticals Inc. Prevention and treatment of acute renal failure and other kidney diseases by inhibition of p53 by siRNA
KR101549364B1 (en) * 2006-03-17 2015-09-01 암비트 바이오사이언시즈 코포레이션 Imidazolothiazole compounds for the treatment of disease
PT2170403E (en) * 2007-06-27 2014-07-17 Quark Pharmaceuticals Inc Compositions and methods for inhibiting expression of pro-apoptotic genes
HUE027982T2 (en) 2007-09-19 2016-11-28 Ambit Biosciences Corp Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea, compositions thereof, and uses therewith
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
CN107417705B (en) * 2017-07-24 2019-07-02 湘潭大学 Imidazo [2,1-b] benzothiazole compound and its synthetic method
IL279972A (en) * 2021-01-05 2022-08-01 Anima Biotech Inc C-myc mrna translation modulators and uses thereof in the treatment of cancer
WO2024010761A1 (en) * 2022-07-03 2024-01-11 Anima Biotech Inc. C-myc mrna translation modulators and uses thereof in the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129432C (en) * 1964-02-29
US4080339A (en) * 1973-09-20 1978-03-21 Pfizer Inc. Imidazo[2,1-b]thiazole and thiazolo[3,2-a]benzimidazole quaternary salts as hypoglycemic agents and growth promotants
GB1541321A (en) * 1976-03-10 1979-02-28 Metabio 2,3-dihydroimidazo(2,1-b)thiazole derivatives and process for their preparation
US4262004A (en) * 1979-06-21 1981-04-14 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazole compositions to treat depressions

Also Published As

Publication number Publication date
US4497817A (en) 1985-02-05
GB2056982A (en) 1981-03-25
ES494397A0 (en) 1981-08-01
ES8106535A1 (en) 1981-08-01
FR2463774A1 (en) 1981-02-27
DE3030982A1 (en) 1981-03-12
IT1166483B (en) 1987-05-06
IT8068303A0 (en) 1980-08-20
FR2463774B1 (en) 1983-10-21
CA1158246A (en) 1983-12-06
ATA425280A (en) 1986-01-15

Similar Documents

Publication Publication Date Title
GB2056982B (en) 2 - phenylimidazo(2,1 - b)benzothiazole derivatives
AU531348B2 (en) 1,8 naphthyridine derivatives
AU503912B2 (en) 2, 3-dihydro-imidazo (2, 1-b) thiazole derivatives
AU2882977A (en) Dihydro imidazo(2,1-b) thiazoles
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
NZ194529A (en) 9,10-dihydro-1h, 4h-pyrazolo (4,3-b)(1,5)benzodiazepin-10-ones
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
AU4486379A (en) 1-oxo-1h-pyrimido(6,1-b)benzthiazole derivatives
AU538119B2 (en) Imidazo(2,1-b)quinazoline derivatives
CS528780A2 (en) Zpusob vyroby substituovanych pyrido-(1,2-a)pyrimidinu
ZA807494B (en) 2,3-indoledione derivatives
AU533589B2 (en) Thiazole derivatives
IL61535A0 (en) 1-oxo-1h-thiazolo(3,2-a)pyrimidine-2-carboxamides
AU534271B2 (en) S-triazolo(3,4-c)benzo-as-triazine derivatives
CS340780A2 (en) Zpusob vyroby pyrazolo (1,5 c) chinazolinovych derivatu
AU500047B2 (en) S-triazolo/5, 1-b/benzothiazoles
AU7028081A (en) 5,6-substituted-2-amino benzothiazole derivatives
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
AU492098B2 (en) IMIDAZO (2, 1-b) THIAZOLES
AU535884B2 (en) 4-aryl-5,6,7,8-tetrahydropyrazolo(3,4-b)-(1,5)diazepine-1h,4 -5,7-diones
GB2042519B (en) 1,1,2-triphenylethane and -ehylene derivatives
AU510553B2 (en) S-Triazolo (3, 4-B) Benzothiazoles
AU6292880A (en) 1,3-thiazolo (3,2-c) benzaxazine derivatives
AU551034B2 (en) Imidazo (2,1-6) thiazole
IE40804B1 (en) Imidazo(2,1-b)thiazoles

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee